Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.

News Releases

view all
    • News in Focus
        • Browse News Releases

        • All Public Company News
        • All Multimedia News
        • View All News Releases

        • Regulatory News

        • D/A/CH Regulatory News
        • UK Regulatory News
        • View All Regulatory News

    • Business & Money
        • Auto & Transportation

        • Aerospace & Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads & Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking & Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers & Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalisation
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls & Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil & Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defence
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation & Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking & Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers & Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines & Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics & Personal Care
        • Fashion
        • Food & Beverages
        • Furniture & Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewellery
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film & Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks & Tourist Attractions
        • Gambling & Casinos
        • Hotels & Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Animal Welfare
        • Corporate Social Responsibility
        • Economic News, Trends & Analysis
        • Education
        • Environmental
        • European Government
        • Labour & Union
        • Natural Disasters
        • Not For Profit
        • Public Safety
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Enquiries
    • Media Enquiries
    • Partnerships
    • Hamburger menu
    • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
    • Send a Release
      • Phone

      • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

      • ALL CONTACT INFO
      • Contact Us

        +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • 2 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      • General Enquiries
      • Media Enquiries
      • Partnerships
      • Client Login
      • Send a Release
      • Resources
      • Journalists
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Regulatory News
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Global OTC Pharmaceutical Market Forecast 2017-2027

      This image opens in the lightbox

      News provided by

      Visiongain Ltd

      24 Aug, 2017, 13:01 GMT

      Share this article

      Share this article


      LONDON, August 24, 2017 /PRNewswire/ --

      Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others

      The Global OTC Pharmaceutical market is expected to grow at a CAGR of 6.5% in the first half of the forecast period. The Global OTC Pharmaceutical market is estimated at $127bn in 2016 and is dominated by the cough, cold and allergy segment which holds 23% share of the Global OTC Pharmaceutical market.

           (Logo: http://mma.prnewswire.com/media/523989/Visiongain_Logo.jpg )

      How this report will benefit you: 

      Read on to discover how you can exploit the future business opportunities emerging in this sector.

      In this brand new 177-page report you will receive 82 tables and 79 figures - all unavailable elsewhere.

      The 177-page report provides clear detailed insight into the Global OTC Pharmaceutical market. Discover the key drivers and challenges affecting the market.

      By ordering and reading our brand new report today you stay better informed and ready to act.

      Report Scope: 

      • Global OTC Pharmaceutical Market forecasts from 2017-2027

      • This report breaks down the revenue forecast of the Global OTC Pharmaceutical market into these leading segments:
      • Analgesics
      • Cough, cold and allergy products
      • Dermatological products
      • Gastrointestinal products
      • Eye Care
      • Smoking Cessation Aids
      • Other products

      Each submarket is further divided by region: North America, South America, Europe, Asia-Pacific and RoW:

      • This report provides individual revenue forecasts to 2027 for these regional and national markets:
      • North America: the US, Canada, Mexico
      • South America: Brazil, Argentina, Paraguay, Bolivia, Rest of South America
      • Europe: Germany, France, the UK, Spain, Italy, Rest of Europe
      • Asia-Pacific: China, Japan, India, Australia, Thailand, Rest of Asia-Pacific
      • Rest of the World: Middle East, Africa, Other Countries

      • Our study provides a SWOT analysis and Porter's Five Forces analysis of the Global OTC Pharmaceutical market

      • This report discusses the leading companies in the Global OTC Pharmaceutical market
      • Bayer AG
      • GlaxoSmithKline (GSK) Consumer Care
      • Perrigo Company PLC
      • Johnson & Johnson
      • Daiichi Sankyo Co., Ltd
      • Pfizer Inc.
      • Procter & Gamble
      • Sanofi S.A
      • Reckitt Benckiser Group PLC
      • Cipla, Inc.

      Visiongain's study is intended for anyone requiring commercial analyses for the Global OTC Pharmaceutical Market. You find data, trends and predictions.

      Buy our report today Global OTC Pharmaceutical Market Forecast 2017-2027: Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others.

      To request a report overview of this report please email Sara Peerun at sara.peerun@visiongain.com or call Tel: +44-(0)-20-7336-6100

      Or click on https://www.visiongain.com/Report/1969/Global-OTC-Pharmaceutical-Market-Forecast-2017-2027

      Companies Mentioned in the Report: 

      Abbott Medical Optics

      Aché Laboratórios Farmacêuticos

      Actavis

      Adams Respiratory Therapeutics

      Akorn

      Alcon

      Allergan

      Alliance Boots

      Almirall

      Amerisource Bergen

      ANVISA

      Apotex

      Arena Pharmaceuticals

      Aspen Pharmacare

      Astellas Pharma

      AstraZeneca

      Aurobindo

      B.F. Ascher & Company

      Bausch & Lomb

      Bayer

      Boehringer Ingelheim

      Boots

      Bristol-Myers Squibb

      Cardinal Health

      Celesio

      China Resources Sanjiu Pharmaceutical

      Ciba

      Cilag

      Cipla

      Costco

      CSPC (China Shijiazhuang Pharmaceutical Group)

      CVS

      Daiichi Sankyo

      Dalkhimpharm

      Dollar General

      Dr. Reddy's Laboratories

      Eisai

      Eli Lilly

      EMS

      Eurofarma

      Fosun Pharma

      Galderma

      Genomma Lab

      GSK

      Guangzhou Pharmaceutical

      Harbin Pharmaceutical Group

      Heritage/Insight

      Hisamitsu

      Hypermacas

      Im Co., Ltd.

      Insight

      Ipca Laboratories

      JB Chemicals

      Johnson & Johnson

      Kangmei Pharmaceutical

      Kowa

      Kroger

      Lion

      LOréal

      Lupin Limited

      Mankind Pharma

      McKesson

      Mead Johnson

      Menarini

      Merck

      Mylan

      North China Pharmaceutical

      Novartis

      Nycomed

      Omega Pharma

      Otsuka

      Paras Pharmaceuticals

      Perrigo

      Pfizer

      Pharmstandard

      Phoenix

      Prestige Brands

      Procter & Gamble

      Purdue Pharma

      Ranbaxy

      Ratiopharm

      Reckitt Benckiser

      Roche

      Rohto

      Roxane Labs

      Sam's Club

      Sandoz

      Sanofi

      Sato

      Sergeant

      Shanghai Pharmaceuticals

      Shionogi

      Sinopharm

      SkyePharma

      Somaxon Pharmaceuticals

      Sotex

      SSL International

      Stada

      Sun Pharma

      Taisho

      Takeda

      Teva

      Torrent Pharmaceuticals

      Typharm

      UCB Pharma

      União Química

      Valeant

      Velcera

      Veropharm

      Vivus

      To see a report overview please email Sara Peerun on sara.peerun@visiongain.com

      Modal title

      Contact PR Newswire

      • +44 (0)20 7454 5110
        from 8 AM - 5:30 PM GMT
      • General Enquiries
      • Media Enquiries
      • Partnerships

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United States
      • Vietnam

      My Services

      • All News Releases
      • PR Newswire Amplify™
      • Resources
      • Journalists
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via Privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Customer Portal
      • Resources
      • Journalists
      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookie Settings
      Copyright © 2026 PR Newswire Europe Limited. All Rights Reserved. A Cision company.